C12N 2810/55
From bacteria
Official title: from bacteria
C12N2810/55 (From bacteria) appears on 26 US grants and 48 published applications in this corpus.
Search patents in C12N- Granted patents
- 26
- Published applications
- 48
- Assignees
- 22
- Inventors
- 74
- Latest grant
- 18 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2001 | 1 | 0 |
| 2002 | 0 | 1 |
| 2003 | 0 | 2 |
| 2004 | 0 | 3 |
| 2005 | 1 | 2 |
| 2006 | 1 | 1 |
| 2007 | 0 | 2 |
| 2008 | 2 | 1 |
| 2009 | 0 | 1 |
| 2010 | 0 | 1 |
| 2011 | 0 | 1 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 1 | 4 |
| 2015 | 2 | 3 |
| 2016 | 1 | 4 |
| 2017 | 0 | 1 |
| 2018 | 1 | 0 |
| 2019 | 2 | 2 |
| 2020 | 1 | 3 |
| 2021 | 0 | 2 |
| 2022 | 6 | 4 |
| 2023 | 1 | 1 |
| 2024 | 2 | 3 |
| 2025 | 1 | 3 |
| 2026 | 3 | 3 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Methods and compositions for enhanced protein production in Bacillus cells18 Aug 2026US 12,709,755 B2Danisco US Inc.
- RNA-guided human genome engineering9 Jun 2026US 12,649,928 B2President and Fellows of Harvard College
- RNA-guided human genome engineering28 Apr 2026US 12,612,643 B2President and Fellows of Harvard College
- CD8 polypeptides, compositions, and methods of using thereof25 Feb 2025US 12,234,473 B2Immatics US, Inc.
- Nucleic acid systems that enable bacteria to specifically target solid tumors via glucose-dependent viability23 Jul 2024US 12,042,517 B2New Portal Limited
- RNA-Guided Human Genome Engineering23 Jul 2026US 2026/0209792 A1President and Fellows of Harvard College
- Modified aav particles16 Jul 2026US 2026/0200989 A1Hoffmann-La Roche Inc.
- A molecular toolkit for heterologous protein secretion in bacteroides species16 Jul 2026US 2026/0200992 A1The Brd. of Trustees of the Univ. of Illinois
- Bacteria-targeting capsid particle, treatment composition, disinfectant, food, bacteria elimination method, bactericidal method, corrosion prevention method, animal treatment method, gene introduction method, bacteria function addition method, method for producing bacteria-targeting capsid particle, and method for producing nucleic acid for bacteria-targeting capsid particle25 Dec 2025US 2025/0387442 A1Jichi Medical University
- Mhc gene group humanized animal5 Jun 2025US 2025/0176511 A1Tokyo Metropolitan Institute of Medical Science
Most cited
By later US patents
- RNA-guided human genome engineering263US 9,023,649 B2President and Fellows of Harvard College · 2015
- RNA-guided human genome engineering136US 9,260,723 B2President and Fellows of Harvard College · 2016
- RNA-guided human genome engineering89US 9,970,024 B2President and Fellows of Harvard College · 2018
- Nucleic acid delivery vehicles45US 6,287,857 B1Genzyme Corporation · 2001
- RNA-guided human genome engineering36US 10,717,990 B2President and Fellows of Harvard College · 2020